wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28534786-D42C08CE-6F36-4CBE-A7C0-39CCD1767860
Q28534786-D42C08CE-6F36-4CBE-A7C0-39CCD1767860
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28534786-D42C08CE-6F36-4CBE-A7C0-39CCD1767860
Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trial
P2860
Q28534786-D42C08CE-6F36-4CBE-A7C0-39CCD1767860
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28534786-D42C08CE-6F36-4CBE-A7C0-39CCD1767860
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
853015b46ac932dfea0fb06e92905d63325fe7e2
P2860
Randomized phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane